Differential effects of spinal 5-HT1A receptor activation and 5-HT2A/2C receptor desensitization by chronic haloperidol

Progress in Neuro-Psychopharmacology and Biological Psychiatry

Volumn 31, Issue 7, 2007, Pages 1449-1455

  Gajendiran, Mahadevan ^a  

^a TOKYO UNIVERSITY OF SCIENCE   (Japan)

Author keywords

Activation; Desensitization; Haloperidol; Motoneurones; Serotonin receptors; Spinal reflex

Indexed keywords

2 DIPROPYLAMINO 8 HYDROXYTETRALIN; 4 IODO 2,5 DIMETHOXYAMPHETAMINE; HALOPERIDOL; SEROTONIN 1A RECEPTOR; SEROTONIN 2A RECEPTOR; SEROTONIN 2C RECEPTOR;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DESENSITIZATION; DRUG INHIBITION; EXTRAPYRAMIDAL SYNDROME; EXTRAPYRAMIDAL SYSTEM; IN VIVO STUDY; MALE; MONOSYNAPTIC REFLEX; MOTONEURON; NERVE EXCITABILITY; NONHUMAN; RAT; SEROTONINERGIC SYSTEM; SPINAL REFLEX;

8-HYDROXY-2-(DI-N-PROPYLAMINO)TETRALIN; AMPHETAMINES; ANIMALS; ANTIPSYCHOTIC AGENTS; DYSKINESIA, DRUG-INDUCED; ELECTROPHYSIOLOGY; HALOPERIDOL; MALE; RATS; RATS, WISTAR; RECEPTOR, SEROTONIN, 5-HT1A; RECEPTOR, SEROTONIN, 5-HT2A; RECEPTOR, SEROTONIN, 5-HT2C; RECEPTORS, DOPAMINE D2; REFLEX, MONOSYNAPTIC; SEROTONIN AGONISTS; SPINAL CORD;

EID: 34548137736     PISSN: 02785846     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pnpbp.2007.06.020     Document Type: Article

References (50)

1. Adams M.R., Brandon E.P., Chartoff E.H., Idzerda R.L., Dorsa D.M., and McKnight G.S. Loss of haloperidol induced gene expression and catalepsy in protein kinase A-deficient mice. Proc Natl Acad Sci U S A 94 (1997) 12157-12161
2. Ase A.R., Amdiss F., Hebert C., Huang N., van Gelder N.M., and Reader T.A. Effects of antipsychotic drugs on dopamine and serotonin contents and metabolites, dopamine and serotonin transporters, and serotonin1A receptors. J Neural Transm 106 (1999) 75-105
3. Ashby Jr. C.R., and Wang R.Y. Effects of antipsychotic drugs on 5-HT2 receptors in the medial prefrontal cortex: microiontophoretic studies. Brain Res 506 (1990) 346-348
4. Bardin L., Auclair A., Kleven M.S., Prinssen E.P., Koek W., Newman-Tancredi A., et al. Pharmacological profiles in rats of novel antipsychotics with combined dopamine D2/serotonin 5-HT1A activity: comparison with typical and atypical conventional antipsychotics. Behav Pharmacol 18 (2007) 103-118
5. Berg K.A., Stout B.D., Maayani S., and Clarke W.P. Differences in rapid desensitization of 5-hydroxytryptamine2A and 5-hydroxytryptamine2C receptor-mediated phospholipase C activation. J Pharmacol Exp Ther 299 (2001) 593-602
6. Borda T., Genaro A.M., and Cremaschi G. Haloperidol effect on intracellular signals system coupled to alpha1-adrenergic receptor in rat cerebral frontal cortex. Cell Signal 11 (1999) 293-300
7. Burnet P.W., Chen C.P., McGowan S., Franklin M., and Harrison P.J. The effects of clozapine and haloperidol on serotonin-1A, -2A and -2C receptor gene expression and serotonin metabolism in the rat forebrain. Neuroscience 73 (1996) 531-540
8. Burnet P.W., Eastwood S.L., and Harrison P.J. 5-HT1A and 5-HT2A receptor mRNAs and binding site densities are differentially altered in schizophrenia. Neuropsychopharmacology 15 (1996) 442-455
9. Burt D.R., Creese I., and Snyder S.H. Antischizophrenic drugs: chronic treatment elevates dopamine receptor binding in brain. Science 196 (1977) 326-328
10. Chouinard G., Annable L., Ross-Chouinard A., and Mercier P. A 5-year prospective longitudinal study of tardive dyskinesia: factors predicting appearance of new cases. J Clin Psychopharmacol 8 (1988) 21S-26S
11. Dwivedi Y., Rizavi H.S., and Pandey G.N. Differential effects of haloperidol and clozapine on [(3)H]cAMP binding, protein kinase A (PKA) activity, and mRNA and protein expression of selective regulatory and catalytic subunit isoforms of PKA in rat brain. J Pharmacol Exp Ther 301 (2002) 197-209
12. Eglen R.M., Jasper J.R., Chang D.J., and Martin G.R. The 5-HT7 receptor: orphan found. Trends Pharmacol Sci 18 (1997) 104-107
13. Foreman R.D. Integration of viscerosomatic sensory input at the spinal level. Prog Brain Res 122 (2000) 209-221
14. Gajendiran M., Seth P., and Ganguly D.K. Involvement of the presynaptic dopamine D2 receptor in the depression of spinal reflex by apomorphine. Neuroreport 7 (1996) 513-516
15. Hanbauer I., Pradhan S., and Yang H.Y. Role of calmodulin in dopaminergic transmission. Ann N Y Acad Sci 356 (1980) 292-303
16. Hasegawa Y., and Ono H. Effects of 8-OH-DPAT, a 5-HT1A receptor agonist, and DOI, a 5-HT2A/2C agonist, on monosynaptic transmission in spinalized rats. Brain Res 738 (1996) 158-161
17. Hino M., Ono H., and Fukuda H. Supraspinal tonic influence on spinal reflexes and involvement in the effect of chlorpromazine. Gen Pharmacol 15 (1984) 155-158
18. Honda M., and Ono H. No involvement of 5-HT(7) or 5-HT(1D) receptors in the (R)-8-OH-DPAT-induced depression of the monosynaptic reflex in spinalized rats. Eur J Pharmacol 427 (2001) 125-129
19. Huganir R.L., and Greengard P. Regulation of neurotransmitter receptor desensitization by protein phosphorylation. Neuron 5 (1990) 555-567
20. Kane J.M., and Smith J.M. Tardive dyskinesia: prevalence and risk factors, 1959 to 1979. Arch Gen Psychiatry 39 (1982) 473-481
21. Kaneko M., Sato K., Horikoshi R., Yaginuma M., Yaginuma N., Shiragata M., and Kumashiro H. Effect of haloperidol on cyclic AMP and inositol trisphosphate in rat striatum in vivo. Prostaglandins Leukot Essent Fatty Acids 46 (1992) 53-57
22. Kaplan G.B., Leite-Morris K.A., and Keith D.J. Differential effects of treatment with typical and atypical antipsychotic drugs on adenylyl cyclase and G proteins. Neurosci Lett 273 (1999) 147-150
23. Kenney M.J., Pickar J.G., Weiss M.L., Saindon C.S., and Fels R.J. Effects of midbrain and spinal cord transections on sympathetic nerve responses to heating. Am J Physiol Regul Integr Comp Physiol 278 (2000) R1329-R1338
24. Kleven M.S., Barret-Grevoz C., Bruins Slot L., and Newman-Tancredi A. Novel antipsychotic agents with 5-HT(1A) agonist properties: role of 5-HT(1A) receptor activation in attenuation of catalepsy induction in rats. Neuropharmacology 49 (2005) 135-143
25. Langer J., Seeber U., Kuschinsky K., and Sontag K.H. Effect of haloperidol on reflex activation of rat alpha-motoneurones. A possible explanation for akinesia and catalepsy?. Naunyn Schmiedebergs Arch Pharmacol 308 (1979) 149-154
26. Lorenc-Koci E., Wolfarth S., and Ossowska K. Haloperidol-increased muscle tone in rats as a model of parkinsonian rigidity. Exp Brain Res 109 (1996) 268-276
27. Lovenberg T.W., Baron B.M., de Lecea L., Miller J.D., Prosser R.A., Rea M.A., et al. A novel adenylyl cyclase-activating serotonin receptor (5-HT7) implicated in the regulation of mammalian circadian rhythms. Neuron 11 (1993) 449-458
28. Maitra K.K., Seth P., Mohanakumar K.P., and Ganguly D.K. Supersensitivity of spinal dopaminergic receptors in rat after chronic haloperidol. Brain Res Bull 28 (1992) 133-135
29. Maitra K.K., Seth P., Ross H.G., Thewissen M., and Ganguly D.K. Presynaptic dopaminergic inhibition of the spinal reflex in rats. Brain Res Bull 28 (1992) 817-819
30. Marlier L., Teilhac J.R., Cerruti C., and Privat A. Autoradiographic mapping of 5-HT1, 5-HT1A, 5-HT1B and 5-HT2 receptors in the rat spinal cord. Brain Res 550 (1991) 15-23
31. Matsuoka I., Maldonado R., Defer N., Noel F., Hanoune J., and Roques B.P. Chronic morphine administration causes region-specific increase of brain type VIII adenylyl cyclase mRNA. Eur J Pharmacol 268 (1994) 215-221
32. McEvoy J.P., Stiller R.L., and Farr R. Plasma haloperidol levels drawn at neuroleptic threshold doses: a pilot study. J Clin Psychopharmacol 6 (1986) 133-138
33. Meltzer H.Y., and Nash J.F. Effects of antipsychotic drugs on serotonin receptors. Pharmacol Rev 43 (1991) 587-604
34. Naidu P.S., and Kulkarni S.K. Effect of 5-HT1A and 5-HT2A/2C receptor modulation on neuroleptic-induced vacuous chewing movements. Eur J Pharmacol 428 (2001) 81-86
35. Neal-Beliveau B.S., Joyce J.N., and Lucki I. Serotonergic involvement in haloperidol-induced catalepsy. J Pharmacol Exp Ther 265 (1993) 207-217
36. Nishizuka Y. Intracellular signaling by hydrolysis of phospholipids and activation of protein kinase C. Science 258 (1992) 607-614
37. Pauwels P.J., and Colpaert F.C. Stereoselectivity of 8-OH-DPAT enantiomers at cloned human 5-HT1D receptor sites. Eur J Pharmacol 300 (1996) 137-139
38. Roth B.L., Nakaki T., Chuang D.M., and Costa E. 5-Hydroxytryptamine2 receptors coupled to phospholipase C in rat aorta: modulation of phosphoinositide turnover by phorbol ester. J Pharmacol Exp Ther 238 (1986) 480-485
39. Scatton B., Dennis T., L'Heureux R., Monfort J.C., Duyckaerts C., and Javoy-Agid F. Degeneration of noradrenergic and serotonergic but not dopaminergic neurones in the lumbar spinal cord of parkinsonian patients. Brain Res 380 (1986) 181-185
40. Schutz L.J., Wolf W.A., and Schutz L.J. Haloperidol increases serotonin (5-HT) 5-HT2C receptors function in caudate. Society for Neuroscience vol. 24 (1998) 1368
41. Seth P., Gajendiran M., and Ganguly D.K. Desensitization of spinal 5-HT1A receptors to 8-OH-DPAT: an in vivo spinal reflex study. Neuroreport 8 (1997) 2489-2493
42. Simon E. Temperature regulation: the spinal cord as a site of extrahypothalamic thermoregulatory functions. Rev Physiol Biochem Pharmacol 71 (1974) 1-76
43. Szczepanik A.M., and Wilmot C.A. Effects of ritanserin on haloperidol-induced dopamine (D2) receptor up-regulation in the rat. Neurosci Lett 231 (1997) 91-94
44. Taylor R.F., and Schramm L.P. Differential effects of spinal transection on sympathetic nerve activities in rats. Am J Physiol 253 (1987) R611-R618
45. Thor K.B., Nickolaus S., and Helke C.J. Autoradiographic localization of 5-hydroxytryptamine1A, 5-hydroxytryptamine1B and 5-hydroxytryptamine1C/2 binding sites in the rat spinal cord. Neuroscience 55 (1993) 235-252
46. Turalba A.V., Leite-Morris K.A., and Kaplan G.B. Antipsychotics regulate cyclic AMP-dependent protein kinase and phosphorylated cyclic AMP response element-binding protein in striatal and cortical brain regions in mice. Neurosci Lett 357 (2004) 53-57
47. Van Oekelen D., Luyten W.H., and Leysen J.E. 5-HT2A and 5-HT2C receptors and their atypical regulation properties. Life Sci 72 (2003) 2429-2449
48. Wilson J., Lin H., Fu D., Javitch J.A., and Strange P.G. Mechanisms of inverse agonism of antipsychotic drugs at the D(2) dopamine receptor: use of a mutant D(2) dopamine receptor that adopts the activated conformation. J Neurochem 77 (2001) 493-504
49. Wolf W.A., Bieganski G.J., Guillen V., and Mignon L. Enhanced 5-HT2C receptor signaling is associated with haloperidol-induced "early onset" vacuous chewing in rats: implications for antipsychotic drug therapy. Psychopharmacology (Berl) 182 (2005) 84-94
50. Yamazaki J., Fukuda H., Nagao T., and Ono H. 5-HT2/5-HT1C receptor-mediated facilitatory action on unit activity of ventral horn cells in rat spinal cord slices. Eur J Pharmacol 220 (1992) 237-242